InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
63,872.11
(
-0.46%
)
Post# of 252969
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: biocqr post# 224292

Monday, 03/25/2019 9:01:41 PM

Monday, March 25, 2019 9:01:41 PM

Post# of 252969

ARVN > first cancer pt dosed using protein degradation MOA...

It's not to same extreme degree as ASMB (with potentially 4 follow-on drugs behind the lead), but bugs me that ARVN has one direct "next generation" version of their lead drug ARV-110 in what looks like much earlier development. Why do they feel they need a next gen version of the lead drug?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up